Pages that link to "Q58947783"
Jump to navigation
Jump to search
The following pages link to Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease (Q58947783):
Displaying 24 items.
- Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality (Q26859793) (← links)
- Plasma levels of the pro-inflammatory protein S100A12 (EN-RAGE) are associated with muscle and fat mass in hemodialysis patients: a cross-sectional study (Q33723012) (← links)
- Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients (Q34362687) (← links)
- Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group bo (Q34493096) (← links)
- Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study (Q35152739) (← links)
- Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT. (Q35837912) (← links)
- sRAGE and risk of diabetes, cardiovascular disease, and death (Q36867450) (← links)
- Atherosclerosis in CKD: differences from the general population. (Q37803336) (← links)
- Role of Advanced Glycation End Products and Its Receptors in the Pathogenesis of Cigarette Smoke-Induced Cardiovascular Disease (Q38523267) (← links)
- Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions (Q38859313) (← links)
- AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease (Q39313922) (← links)
- Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort (Q40298930) (← links)
- Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation. (Q45339625) (← links)
- Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease (Q47676591) (← links)
- Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients. (Q48180502) (← links)
- Advanced glycation end products and soluble receptor as markers of oxidative stress in children on hemodialysis. (Q53790164) (← links)
- Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels. (Q54764181) (← links)
- Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients. (Q55128551) (← links)
- Low Glucose Degradation Product Peritoneal Dialysis Regimen Is Associated With Lower Plasma EN-RAGE and HMGB-1 Proinflammatory Ligands of Receptor for Advanced Glycation End Products (Q57825113) (← links)
- Pregnancy-associated plasma protein A (PAPP-A) and soluble receptor for advanced glycation end products (sRAGE) – intra- and inter-individual variability in chronic hemodialysis patients (Q57825168) (← links)
- Serum S100A12 (EN-RAGE) Levels in Patients with Decreased Renal Function and Subclinical Chronic Inflammatory Disease (Q57825196) (← links)
- Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes. (Q64912818) (← links)
- Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients (Q84280583) (← links)
- The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity (Q84614488) (← links)